Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib with Paclitaxel and Gemcitabine in HER2-negative Breast Cancer
NCT01070706Phase 2Completed
- Sponsor
- Jungsil Ro
- Start
- Mar 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in breast cancer, sponsored by Jungsil Ro. Started Mar 2009; status: completed.
02
Drugs
sunitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01070706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01070706.